At a glance
The Clinical Laboratory Improvement Advisory Committee (CLIAC) may convene workgroups to discuss issues and gather information on specific topics. The output of the workgroup will be a summary report based on research activities and information gathered during workgroup discussions.
Overview
CLIAC may convene workgroups to discuss issues and gather information on specific topics. These topics are related to matters identified through Committee discussions or outlined in the CLIAC Charter. The output of the workgroup will be a summary report based on research activities and information gathered during workgroup discussions.
Workgroup present reports at future CLIAC meetings for Committee discussion, deliberation, and potential recommendations to the:
- Secretary, Department of Health and Human Services.
- Assistant Secretary for Health, Department of Health and Human Services.
- Director, Centers for Disease Control and Prevention.
- Commissioner, Food and Drug Administration.
- Administrator, Centers for Medicare & Medicaid Services.
The advice and guidance from CLIAC pertain to issues related to improvement in clinical laboratory quality and laboratory medicine. CLIAC also addresses specific questions related to possible revisions of the Clinical Laboratory Improvement Amendments of 1988 (CLIA) standards.
Workgroups
Resources
Find summaries of past meetings with details on CLIAC workgroup activities.
Contact
Email: CLIAC@cdc.gov